EarCentric EasyCharge vs EarCentric EX2

The EarCentric EasyCharge is a budget-priced prescription behind-the-ear hearing aid released in 2023, earning a C grade with a SoundScore of 2.7/5 in our lab testing. At $229, it sits at the entry level of the prescription hearing aid market. In our standardized testing, this device showed a significant performance gap compared to the prescription hearing aid category. Speech clarity scores were notably low, measuring 2.32 points below the category average in quiet environments and 0.96 points below average in noisy settings. Music streaming performance was similarly limited at 0.0/5, falling 2.64 points below average. Own-voice comfort scored 1.9/5, which is 0.85 points below the category norm. The EasyCharge's standout feature is its excellent feedback handling, scoring a perfect 5.0/5—0.29 points above the category average of 4.71. This means users are unlikely to experience whistling or squealing during everyday use. The device also offers convenient rechargeable batteries. Within the same budget price range, the RxEars Rxi achieves significantly stronger overall performance with a 4.09/5 SoundScore. Consumers prioritizing sound quality on a tight budget may find better value elsewhere, though the EasyCharge's feedback stability and rechargeable design could appeal to users with modest amplification needs who value convenience over maximum speech clarity.

The EarCentric EX2 is a budget-priced prescription behind-the-ear hearing aid released in 2021, earning a C grade with a SoundScore of 2.7/5 in HearAdvisor's lab testing. At $218, it ranks #33 of 36 prescription hearing aids tested, placing it in the bottom 11% of its category. In our testing, the EX2 showed a significant split in performance. Feedback handling was excellent at 4.7/5, essentially matching the category average and demonstrating stable operation during movement. However, speech performance was notably limited, with both speech in quiet and speech in noise scoring 1.0/5—well below the category averages of 3.32 and 1.96 respectively. Music streaming scored 0.0/5, falling 2.64 points below the prescription category average of 2.64/5. Own-voice comfort scored 2.3/5, a mixed result that sits 0.45 points below the category average. The device uses a rechargeable battery, which adds convenience for daily use. Notably, tuning did not improve performance in our testing—the Initial and Tuned fit scores were identical at 2.7/5. Budget-conscious shoppers in this price range may want to compare alternatives. The RxEars Rxi scored 4.09/5 at a similar price point, while OTC options like the Audien Hearing Atom offer comparable or better sound performance at lower prices. The EX2 may suit users who prioritize feedback stability and rechargeable convenience over speech clarity, but its limited speech performance is a significant tradeoff.